FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome
Abstract
Prevention of SARS-CoV-2 entry in cells through the modulation of viral host receptors, such as ACE2, could represent a new therapeutic approach complementing vaccination. However, the mechanisms controlling ACE2 expression remain elusive. Here, we identify the farnesoid X receptor (FXR) as a direct regulator of ACE2 transcription in multiple COVID19-affected tissues, including the gastrointestinal and respiratory systems. We demonstrate that FXR antagonists, including the over-the-counter compound z-guggulsterone (ZGG) and the off-patent drug ursodeoxycholic acid (UDCA), downregulate ACE2 levels, and reduce susceptibility to SARS-CoV-2 infection in lung, cholangiocyte and gut organoids. We then show that therapeutic levels of UDCA downregulate ACE2 in human organs perfused ex situ and reduce SARS-CoV-2 infection ex vivo. Finally, we perform a retrospective study using registry data and identify a correlation between UDCA treatment and positive clinical outcomes following SARS-CoV-2 infection, including hospitalisation, ICU admission and death. In conclusion, we identify a novel function of FXR in controlling ACE2 expression and provide evidence that this approach could be beneficial for reducing SARS-CoV-2 infection, thereby paving the road for future clinical trials.
Competing Interest Statement
F.S., L.V. and K.S.-P. are founders and shareholders of Bilitech LTD. L.V. is a founder and shareholder of DEFINIGEN. The remaining authors have no competing interests to disclose.
Subject Area
- Biochemistry (11571)
- Bioengineering (8622)
- Bioinformatics (28868)
- Biophysics (14803)
- Cancer Biology (11941)
- Cell Biology (17168)
- Clinical Trials (138)
- Developmental Biology (9302)
- Ecology (14019)
- Epidemiology (2067)
- Evolutionary Biology (18128)
- Genetics (12145)
- Genomics (16616)
- Immunology (11707)
- Microbiology (27692)
- Molecular Biology (11387)
- Neuroscience (60096)
- Paleontology (447)
- Pathology (1847)
- Pharmacology and Toxicology (3184)
- Physiology (4878)
- Plant Biology (10278)
- Synthetic Biology (2849)
- Systems Biology (7289)
- Zoology (1619)